The Valley Desk

NCT04197986 · Interventional trial

Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations

Overall registry status Terminated

Phase 3

Conditions Upper Tract Urothelial Carcinomas, Urothelial Bladder Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov